Cargando…
Differences between immunodeficient mice generated by classical gene targeting and CRISPR/Cas9-mediated gene knockout
Immunodeficient mice are widely used for pre-clinical studies to understand various human diseases. Here, we report the generation of four immunodeficient mouse models using CRISPR/Cas9 system without inserting any foreign gene sequences such as Neo(R) cassettes and their characterization. By elimin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986857/ https://www.ncbi.nlm.nih.gov/pubmed/29594927 http://dx.doi.org/10.1007/s11248-018-0069-y |
Sumario: | Immunodeficient mice are widely used for pre-clinical studies to understand various human diseases. Here, we report the generation of four immunodeficient mouse models using CRISPR/Cas9 system without inserting any foreign gene sequences such as Neo(R) cassettes and their characterization. By eliminating any possible effects of adding a Neo(R) cassette, our mouse models may allow us to better elucidate the in vivo functions of each gene. Our FVB-Rag2(−/−), B6-Rag2(−/−), and BALB/c-Prkdc(−/−) mice showed phenotypes similar to those of the earlier immunodeficient mouse models, including a lack of mature B cells and T cells and an increase in the number of CD45(+)DX-5(+) natural killer cells. However, B6-Il2rg(−/−) mice had a unique phenotype, with a lack of mature B cells, increased number of T cells, and decreased number of natural killer cells. Additionally, serum immunoglobulin levels in all four immunodeficient mouse models were significantly reduced when compared to those in wild-type mice with the exception of IgM in B6-Il2rg(−/−) mice. These results indicate that our immunodeficient mouse models are a robust tool for in vivo studies of the immune system and will provide new insights into the variation in phenotypic outcomes resulting from different gene-targeting methodologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11248-018-0069-y) contains supplementary material, which is available to authorized users. |
---|